Is ABT or CVS cheaper?

On trailing earnings, ABT is cheaper: ABT trades at a 24.56 P/E and CVS at 44.92.

Which has grown faster, ABT or CVS?

Over the past five years, CVS grew revenue faster — ABT at a 3.87% CAGR versus CVS at 8.52%.

Does ABT or CVS pay a bigger dividend?

ABT yields 2.77% and CVS yields 2.61% based on trailing dividends and the latest price.

Is ABT or CVS more profitable?

ABT runs the higher net margin — ABT at 13.91% versus CVS at 0.72%.

Which has been the better investment, ABT or CVS?

Over the past 10-year, ABT delivered the higher annualized total return — ABT at 10.72% versus CVS at 3.66%. Past performance doesn't predict future results.

Abbott Laboratories (ABT) vs CVS Health Corporation (CVS)

ABT leads on 10 of 16 compared metrics.

A side-by-side comparison of Abbott Laboratories and CVS Health Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

CVS Health Corporation

$130.09B

$101.96Healthcare

Total return — ABT vs CVS

growth of $100 · last 30y

ABT +814.7%CVS +886.1%CVS compounded faster

ABT CVS

ABT vs CVS: by the numbers

•ABT is the larger company ($153.59B vs $130.09B market cap).
•ABT trades at the lower earnings multiple (24.56 vs 44.92 P/E).
•ABT converts more revenue to profit (13.91% vs 0.72% net margin).
•CVS grew revenue faster over the past five years (8.52% vs 3.87% CAGR).
•ABT pays the higher dividend yield (2.77% vs 2.61%).

Which is better, ABT or CVS?

Metric tally: ABT 10 · CVS 6

It depends on what you're optimizing for:

ValueABT(lower P/E)

GrowthCVS(faster 5Y revenue CAGR)

IncomeABT(higher dividend yield)

QualityABT(higher ROIC)

Valuation

Metric	ABT	CVS
P/E ratio	24.56●	44.92
Forward P/E	14.56	12.17●
P/S ratio	3.41	0.32●
P/B ratio	2.96	1.68●
PEG ratio	2.99	—
EV / EBITDA	17.30●	17.90
FCF yield	4.79%	5.67%●

Profitability

Metric	ABT	CVS
Gross margin	56.38%●	13.87%
Operating margin	18.17%●	1.46%
Net margin	13.91%●	0.72%
ROE	12.06%●	3.79%
ROIC	8.43%●	4.72%

Dividends

Metric	ABT	CVS
Dividend yield	2.77%●	2.61%
Payout ratio	65.24%	190.00%

Growth (annualized)

Metric	ABT	CVS
Revenue CAGR (5Y)	3.87%	8.52%●
EPS CAGR (5Y)	8.22%●	-23.89%
FCF CAGR (5Y)	-0.61%●	-10.57%
Total return CAGR (5Y)	-2.49%	7.06%●

Frequently asked

Which is better, ABT or CVS?: It depends on your goal. value: ABT (lower P/E); growth: CVS (faster 5Y revenue CAGR); income: ABT (higher dividend yield); quality: ABT (higher ROIC). Across all compared metrics, ABT leads 10 to 6.
Is ABT or CVS cheaper?: On trailing earnings, ABT is cheaper: ABT trades at a 24.56 P/E and CVS at 44.92.
Which has grown faster, ABT or CVS?: Over the past five years, CVS grew revenue faster — ABT at a 3.87% CAGR versus CVS at 8.52%.
Does ABT or CVS pay a bigger dividend?: ABT yields 2.77% and CVS yields 2.61% based on trailing dividends and the latest price.
Is ABT or CVS more profitable?: ABT runs the higher net margin — ABT at 13.91% versus CVS at 0.72%.
Which has been the better investment, ABT or CVS?: Over the past 10-year, ABT delivered the higher annualized total return — ABT at 10.72% versus CVS at 3.66%. Past performance doesn't predict future results.

Go deeper

Full ABT analysis Full CVS analysis Interactive comparison tool

Dig into the metrics

Abbott Laboratories P/E ratio CVS Health P/E ratio Abbott Laboratories dividend yield CVS Health dividend yield Abbott Laboratories ROE CVS Health ROE Abbott Laboratories operating margin CVS Health operating margin Abbott Laboratories revenue growth CVS Health revenue growth Abbott Laboratories free cash flow CVS Health free cash flow

Abbott Laboratories & CVS Health appear in these rankings

Highest Dividend Yield Stocks Dividend Aristocrats Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.